Literature DB >> 20429684

The association between ALS and population density: A population based study.

Kirsten M Scott1, Kumar Abhinav, Lokesh Wijesekera, Jeban Ganesalingam, Laura H Goldstein, Anna Janssen, Andrew Dougherty, Emma Willey, Biba R Stanton, Martin R Turner, Mary-Ann Ampong, Mohammed Sakel, Richard Orrell, Robin Howard, Christopher E Shaw, P Nigel Leigh, Ammar Al-Chalabi.   

Abstract

We aimed to assess whether rural residence is associated with amyotrophic lateral sclerosis in the south-east of England using a population based register. Previous studies in different populations have produced contradictory findings. Residence defined by London borough or non-metropolitan district at time of diagnosis was recorded for each incident case in the South-East England ALS Register between 1995 and 2005. Each of the 26 boroughs or districts of the catchment area of the register was classified according to population density. Age- and sex-adjusted incidence of ALS was calculated for each region and the relationship with population density tested by linear regression, thereby controlling for the underlying population structure. We found that population density in region of residence at diagnosis explained 25% of the variance in ALS rates (r = 0.5, p < 0.01). Thus, in this cohort in the south-east of England, people with ALS were more likely to be resident in areas of high population density at diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20429684      PMCID: PMC3205411          DOI: 10.3109/17482961003754552

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  20 in total

1.  Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption.

Authors:  L M Nelson; V McGuire; W T Longstreth; C Matkin
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

2.  Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964-1998.

Authors:  Vittorio Govoni; Enrico Granieri; Elisa Fallica; Ilaria Casetta
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

Review 3.  Amyotrophic lateral sclerosis: toxins and environment.

Authors:  J D Mitchell
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-09

4.  Paraoxonase cluster polymorphisms are associated with sporadic ALS.

Authors:  M Saeed; N Siddique; W Y Hung; E Usacheva; E Liu; R L Sufit; S L Heller; J L Haines; M Pericak-Vance; T Siddique
Journal:  Neurology       Date:  2006-07-05       Impact factor: 9.910

Review 5.  An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis.

Authors:  Carmel Armon
Journal:  Neuroepidemiology       Date:  2003 Jul-Aug       Impact factor: 3.282

6.  The epidemiology of ALS in Modena, Italy.

Authors:  Jessica Mandrioli; Pietro Faglioni; Elisa Merelli; Patrizia Sola
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

Review 7.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues.

Authors:  G Logroscino; B J Traynor; O Hardiman; A Chio'; P Couratier; J D Mitchell; R J Swingler; E Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01       Impact factor: 10.154

Review 8.  Motor neuron disease in the Province of Turin, Italy, 1971-1980.

Authors:  M Leone; A Chio; P Mortara; M G Rosso; D Schiffer
Journal:  Acta Neurol Scand       Date:  1983-11       Impact factor: 3.209

9.  Interaction between PON1 and population density in amyotrophic lateral sclerosis.

Authors:  Frank P Diekstra; Ana Beleza-Meireles; Nigel P Leigh; Christopher E Shaw; Ammar Al-Chalabi
Journal:  Neuroreport       Date:  2009-01-28       Impact factor: 1.837

10.  A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.

Authors:  A-M Wills; S Cronin; A Slowik; D Kasperaviciute; M A Van Es; J M Morahan; P N Valdmanis; V Meininger; J Melki; C E Shaw; G A Rouleau; E M C Fisher; P J Shaw; K E Morrison; R Pamphlett; L H Van den Berg; D A Figlewicz; P M Andersen; A Al-Chalabi; O Hardiman; S Purcell; J E Landers; R H Brown
Journal:  Neurology       Date:  2009-03-25       Impact factor: 9.910

View more
  6 in total

1.  Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009.

Authors:  Maura Pugliatti; Leslie D Parish; Paola Cossu; Stefania Leoni; Anna Ticca; M Valeria Saddi; Enzo Ortu; Sebastiano Traccis; Giuseppe Borghero; Roberta Puddu; Adriano Chiò; Pietro Pirina
Journal:  J Neurol       Date:  2012-09-30       Impact factor: 4.849

Review 2.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

3.  Neurological deaths of American adults (55-74) and the over 75's by sex compared with 20 Western countries 1989-2010: Cause for concern.

Authors:  Colin Pritchard; Emily Rosenorn-Lanng
Journal:  Surg Neurol Int       Date:  2015-07-23

4.  Different occupations associated with amyotrophic lateral sclerosis: is diesel exhaust the link?

Authors:  Roger Pamphlett; Anna Rikard-Bell
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 5.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

Review 6.  Is Population Density Associated with Non-Communicable Disease in Western Developed Countries? A Systematic Review.

Authors:  Elaine Ruth Carnegie; Greig Inglis; Annie Taylor; Anna Bak-Klimek; Ogochukwu Okoye
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.